UPDATE : Monday, September 7, 2020
상단여백
Celgene Korea names new CEO
Celgene Korea has elected Ham Tae-jin as its new CEO, the company said Tues...
by Marian Chu  |  2017-09-05 14:22
라인
Korean start-up Sky Labs wins in Bayer innovation program
Bayer (CEO: Werner Baurmann) said Tuesday it selected four startups, includ...
by Marian Chu  |  2017-09-05 11:11
라인
Ahngook gets state support for new drug
Ahngook Pharmaceuticals said Tuesday it has secured the government’s suppor...
by Lee Han-soo  |  2017-09-05 10:53
라인
Celgene’s leukemia drug gets extended insurance coverage
Celgene said Monday its myelodysplastic syndrome (MS) treatment Vidaza (Ing...
by Lee Han-soo  |  2017-09-04 17:34
라인
Korea UCB gets approval for hemophilia treatment
Korea UCB (CEO: Lee Young-joo) said Tuesday the Ministry of Food and Drug S...
by Marian Chu  |  2017-09-04 15:32
라인
Bluegreen, Haim Bio sign strategic alliance agreement
Haim Bio 하임바이오, a venture company for new bio drugs, entered into a strateg...
by Lee Han-soo  |  2017-09-04 15:11
라인
Roche gets insurance coverage for pregnancy complication detection test
Roche Diagnostics Korea said its blood test for a pregnancy complication ca...
by Marian Chu  |  2017-09-04 11:45
라인
CJ Healthcare submits new drug application for Tegoprazan
CJ Healthcare said Monday it has submitted new drug application with the Mi...
by Lee Han-soo  |  2017-09-04 11:32
라인
Eisai gets insurance coverage for thyroid cancer drug
Eisai Korea said Friday its thyroid cancer treatment Lenvima (ingredient: l...
by Marian Chu  |  2017-09-01 13:59
라인
Quratis applies for P2 clinical trial for Korea’s first adult tuberculosis vaccine
Quratis announced Wednesday that the company had applied for the phase 2 of...
by Lee Han-soo  |  2017-09-01 12:04
라인
Gilead, Yuhan to jointly promote hepatitis C drugs
Gilead Sciences Korea and Yuhan Corporation said Thursday the two companies...
by Marian Chu  |  2017-08-31 17:08
라인
Abbvie gets approval for phase 3 clinical trials to treat Crohn’s disease
Abbvie’s new drug Risankizumab, being developed to treat the Crohn’s diseas...
by Lee Hye-seon  |  2017-08-31 15:49
라인
Huons to export botulinum toxin worth W100 bil.
Huons said Thursday it has agreed with major companies from Europe, Russia ...
by Constance Williams  |  2017-08-31 15:23
라인
Hanmi to manage JVM’s overseas business
Hanmi Pharmaceuticals said Thursday that it will directly manage the overse...
by Lee Han-soo  |  2017-08-31 13:51
라인
Opdivo proves competence among local immunotherapies
Ono Pharma Korea and Bristol-Myers Squibb (BMS) Korea said Thursday its blo...
by Marian Chu  |  2017-08-31 13:47
라인
Novartis gains historic FDA approval for CAR-T leukemia therapy
The U.S. Food and Drug Administration Wednesday approved Novartis’ CAR-T tr...
by Marian Chu  |  2017-08-31 10:52
라인
Gliatamin trademark controversy to head to Supreme Court
Daewoong Bio said Thursday it will immediately appeal to the Supreme Court ...
by Lee Han-soo  |  2017-08-31 10:00
라인
J&J Innovation opens Seoul competition for medical innovation
Johnson & Johnson (J&J) Innovation launched its Seoul Innovation QuickFire ...
by Marian Chu  |  2017-08-31 09:13
라인
Annual output of hypertension, hyperlipidemia drugs surpasses ￦1 tri. respectively
The manufacturing output of the antiarteriosclerotic agent, antibiotic, ant...
by Lee Hye-seon  |  2017-08-30 16:08
라인
Diabetes, cardiovascular generics actively developed in H1
The Ministry of Food and Drug Safety said Wednesday it has approved 70 case...
by Marian Chu  |  2017-08-30 14:59
-이전111112113114115116117118119120-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top